Serelaxin in acute heart failure patients with preserved left ventricular ejection fraction: results from the RELAX-AHF trial

23.04.20141686
Serelaxin is effective in relieving dyspnoea and improving multiple outcomes in acute heart failure (AHF).

Treatment with higher dosages of heart failure medication is associated with improved outcome following cardiac resynchronization therapy

22.04.20141469
Cardiac resynchronization therapy (CRT) is associated with improved morbidity and mortality in patients with chronic heart failure (CHF) on optimal medical therapy.

A prospective study about impact of renal dysfunction and morbidity and mortality on cardiovascular events after ischemic stroke

21.04.20141672
The aim of our prospective study was to define the impact of renal dysfunction on future cardiovascular events and total mortality in 390 patients suffering from ischemic stroke.

Current Evidence on Treatment of Patients With Chronic Systolic Heart Failure and Renal Insufficiency: Practical Considerations From Published Data

18.04.20142433
What is the current evidence regarding the interactions between heart failure (HF) and renal dysfunction, and what is the effect of key disease-modifying therapies used in HF in patients with renal dysfunction?

EMA: Don't Combine ARBs, ACE Inhibitors, and Direct Renin Inhibitors

17.04.20142147
No two drug classes that act separately on the renin-angiotensin system (RAS) should be used in combination, the European Medicines Agency (EMA) warned today.

Educational forum for young cardiologists

16.04.20142060
II scientific and educational forum for young cardiologists was held in Moscow on 2-3 of April.

Cardiologists: Know the signs of Lyme disease

16.04.20141552
Spring has arrived, and along with warmer weather and blossoming tree buds, a seasonal risk looms, especially for outdoor enthusiasts.
Данный сайт и вся информация на нём предназначена для медицинских работников. Продолжая просмотр, вы соглашаетесь и подтверждаете, что являетесь медицинским работником.